Multidrug resistant transgenic mice as a novel pharmacologic tool

Bioessays 13 (8):381-387 (1991)
  Copy   BIBTEX

Abstract

Multidrug resistance resulting from expression of an energy‐dependent drug efflux pump encoded by the human MDR1 gene is a major impediment to effective cancer therapy. Pharmacologic intervention aimed at inhibiting this multidrug transporter should improve existing chemotherapy of human cancer, but drug development has been delayed by the difficulty and expense of developing valid animal models. Using recombinant DNA technology, a transgenic mouse has been engineered whose bone marrow is protected from the toxic effects of chemotherapy by expression of the MDR1 gene. This animal system allows the rapid screening of drugs which inhibit the multidrug transporter and heralds a new era of using transgenic animals for pharmacologic screening.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 90,616

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Transgenic mice.Heiner Westphal - 1987 - Bioessays 6 (2):73-76.
We have always been transgenic.Steve Baker & Carol Gigliotti - 2006 - AI and Society 20 (1):35-48.
Tool use and constructions.Michael A. Arbib - 2012 - Behavioral and Brain Sciences 35 (4):218-219.

Analytics

Added to PP
2013-11-23

Downloads
12 (#929,405)

6 months
1 (#1,040,386)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references